SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001104659-20-033184
Filing Date
2020-03-13
Accepted
2020-03-13 16:52:16
Documents
1
Group Members
VERSANT VANTAGE I GP, L.P.VERSANT VANTAGE I GP-GP, LLCVERSANT VANTAGE I, L.P.VERSANT VENTURES VI GP, L.P.VERSANT VENTURES VI GP-GP, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13D a20-12644_1sc13d.htm SC 13D 287276
  Complete submission text file 0001104659-20-033184.txt   289066
Mailing Address ONE SANSOME STREET, SUITE 3630 SAN FRANCISCO CA 94104
Business Address ONE SANSOME STREET, SUITE 3630 SAN FRANCISCO CA 94104 (415) 801-8100
Versant Venture Capital VI, L.P. (Filed by) CIK: 0001687880 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D

Mailing Address TWO COMMERCE SQUARE 2001 MARKET STREET, 28TH FLOOR PHILADELPHIA PA 19103
Business Address TWO COMMERCE SQUARE 2001 MARKET STREET, 28TH FLOOR PHILADELPHIA PA 19103 2678660312
Passage BIO, Inc. (Subject) CIK: 0001787297 (see all company filings)

IRS No.: 822729751 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-91451 | Film No.: 20713528
SIC: 2836 Biological Products, (No Diagnostic Substances)